Evidence map›Paper›PMID 10973457›Full record

ArticleClinical and diagnostic laboratory immunology2000

Subtilisin increases macromolecular efflux from the oral mucosa.

I Rubinstein

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

I RubinsteinDepartment of Medicine and Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago, and VA Chicago Healthcare System West Side Division, Chicago, Illinois 60612, USA. IRubinst@uic.edu
University of Illinois Chicago · US

Funding

SMOKLESS TOBACCO: MECHANISMS OF BUCCAL MUCOSA INJURYR01DE010347 · NIDCR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI RUBINSTEIN, ISRAEL · 1993 to 1995
–
NIDCR NIH HHS DE00386NIDCR NIH HHS DE10347
6 · The paper itself

Abstract

The purpose of this study was to determine whether subtilisin, a potent serine proteinase derived from Bacillus species contaminating smokeless tobacco, increases macromolecular efflux from the oral mucosa and, if so, whether local elaboration of bradykinin mediates this response. Using intravital microscopy, I found that suffusion of subtilisin elicits significant, concentration-dependent leaky site formation and an increase in the clearance of fluorescein isothiocyanate-labeled dextran (molecular mass, 70 kDa) from the in situ hamster cheek pouch (P<0.05). Heat-inactivated subtilisin had no significant effects on macromolecular efflux. Subtilisin-induced responses were significantly attenuated by Hoe 140 and NPC 17647, two structurally distinct selective bradykinin B(2) receptor antagonists, but not by des-Arg(9)-[Leu(8)]bradykinin, a selective bradykinin B(1) receptor antagonist, or CP-96,345, a selective neurokinin-1 receptor antagonist. Aprotinin, but not leupeptin, significantly attenuated subtilisin-induced increase in macromolecular efflux. Indomethacin had no significant effects on subtilisin-induced responses. Collectively, these data indicate that subtilisin increases the macromolecular efflux from the in situ hamster cheek pouch in a catalytic-site-dependent fashion through local elaboration of bradykinin. This response does not involve the stimulation of local afferent nerves or the production of prostaglandins.

Indexed as

AnimalsAprotininBiphenyl CompoundsBradykininBradykinin Receptor AntagonistsCricetinaeCyclooxygenase InhibitorsCysteine Proteinase InhibitorsIndomethacinLeupeptinsMacromolecular SubstancesMaleMesocricetusMouth MucosaNeurokinin-1 Receptor AntagonistsSerine Proteinase InhibitorsAprotininBiphenyl CompoundsBradykininbradykinin, des-Arg(9)-Bradykinin Receptor AntagonistsCP 96345Cyclooxygenase InhibitorsCysteine Proteinase InhibitorsicatibantIndomethacinleupeptinLeupeptinsMacromolecular SubstancesNeurokinin-1 Receptor AntagonistsSerine Proteinase InhibitorsSubtilisin

Identifiers

PMID10973457
PMCPMC95958
OpenAlexW2138139058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.